# Iggenix, Inc.

Canonical: https://abierto.us/vendors/iggenix-inc-hbp9hfyhb3q4

- UEI: HBP9HFYHB3Q4
- CAGE: 8KPW3
- Location: South San Francisco, CA
- Awards in window: 1 (2 transactions), $100,000 obligated, September 4, 2024 to September 23, 2025

## Awarding agencies

- Food and Drug Administration: 1 awards, $100,000

## Industries

- 325414 Biological Product (except Diagnostic) Manufacturing: $100,000

## Competition

- Competed Under SAP: 1 awards

## Solicitations won

- Fel d 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA/ImmunoEnzymetric Assay (IEMA) (FDARFQ125149). https://abierto.us/opportunities/fdarfq125149

## Largest awards

- 75F40124P00438 (purchase order): $100,000, FDA Office of Acq Grant SVCS. Fel D 1-Specific Human Ige Class Switched to Ige Monoclonal Antibodies. https://www.usaspending.gov/award/CONT_AWD_75F40124P00438_7524_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/iggenix-inc-hbp9hfyhb3q4.